Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$46.03

0.72 (1.59%)

04:55
11/30/16
11/30
04:55
11/30/16
04:55

Alnylam management to meet with Jefferies

Meeting to be held in New York on November 30 hosted by Jefferies.

  • 30

    Nov

  • 30

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

ALNY Alnylam
$46.03

0.72 (1.59%)

10/24/16
PIPR
10/24/16
NO CHANGE
Target $106
PIPR
Overweight
Alnylam oversold following trial stop, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says shares of Alnylam Pharmaceuticals are down 48% since the company said it was discontinuing the Phase III ENDEAVOR trial of revusiran. The analyst believes the death imbalance in the trial was either a revusiran specific or hATTR-CM disease issue that does not apply to the rest of Alnylam's RNAi pipeline. He recommends owning the stock now and reiterates an Overweight rating on Alnylam with a $106 price target.
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Piper sees Biotech rally continuing into 2017, lays out five to own
Piper Jaffray analyst Edward Tenthoff expects the rally in Biotechs, following "the trifecta" of a Trump Presidential election, Republican Congress sweep and defeat of Prop 61 in California, to continue into 2017. He recommends focusing on shares of Vertex (VRTX), Regeneron (REGN), Alnylam (ALNY), Exelixis (EXEL) and OncoMed (OMED). Tenthoff has a Neutral rating on Regeneron and Overweight ratings on the other four names.
11/15/16
PIPR
11/15/16
NO CHANGE
Target $106
PIPR
Overweight
Alnylam selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using today's selloff in shares of Alnylam Pharmaceuticals (ALNY) as a buying opportunity. Alnylam's partner The Medicine's Company (MDCO) presented today positive interim safety and efficacy data from the Phase II ORION-1 study of inclisiran, but the stock is weak today on one fatal heart attack in the 500mg inclisiran arm unrelated to study drug, Tenthoff tells investors in a research note. The analyst was impressed by the drug's efficacy and reiterates an Overweight rating on Alnylam with a $106 price target. The stock is down 3% to $48.36 in afternoon trading.
11/16/16
NEED
11/16/16
NO CHANGE
Target $98
NEED
Buy
Alnylam price target lowered to $98 from $137 at Needham
Needham analyst Alan Carr lowered his price target for Alnylam (ALNY) to $98 from $137 after the company announced that collaborator Sanofi (SNY) exercised its option to co-develop and co-commercialize fitusiran, with the analyst adjusting his models to reflect Sanofi taking greater share of revenue. He also notes that Alnylam's collaborator The Medicines Co. (MDCO) announced positive Phase 2 PCSK9 results. Carr reiterates a Buy rating on Alnylam's shares.

TODAY'S FREE FLY STORIES

RY

Royal Bank of Canada

$70.96

-0.07 (-0.10%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Royal Bank of Canada management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CBG

CBRE Group

$36.48

1.13 (3.20%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
CBRE Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

WGO

Winnebago

$35.15

0.75 (2.18%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Winnebago management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

HAIN

Hain Celestial

$33.63

2.03 (6.42%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Hain Celestial management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

HQY

HealthEquity

$51.12

-0.63 (-1.22%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
HealthEquity management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

04:55
06/27/17
06/27
04:55
06/27/17
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

LPI

Laredo Petroleum

$9.79

0.02 (0.20%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Laredo Petroleum management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

MPWR

Monolithic Power

$99.51

0.93 (0.94%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Monolithic Power management to meet with Oppeneimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

04:55
06/27/17
06/27
04:55
06/27/17
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

04:55
06/27/17
06/27
04:55
06/27/17
04:55
General news
Breaking General news story  »

Federal Reserve Chair…

NFG

National Fuel

$56.71

0.34 (0.60%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
National Fuel management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

IMGN

ImmunoGen

$6.82

0.76 (12.54%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
ImmunoGen management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

SAVE

Spirit Airlines

$52.34

-0.21 (-0.40%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Spirit Airlines management to meet with Raymond James »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MDSO

Medidata

$77.73

-2.17 (-2.72%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Medidata management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

04:55
06/27/17
06/27
04:55
06/27/17
04:55
General news
Breaking General news story  »

Week of 6/24 Redbook to…

YY

YY

$58.52

-0.28 (-0.48%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
YY management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

04:55
06/27/17
06/27
04:55
06/27/17
04:55
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

TRP

TransCanada

$47.48

0.49 (1.04%)

, CHK

Chesapeake

$4.67

0.1 (2.19%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
JPMorgan to hold a conference »

2017 Energy Equity…

TRP

TransCanada

$47.48

0.49 (1.04%)

CHK

Chesapeake

$4.67

0.1 (2.19%)

FANG

Diamondback Energy

$87.30

-1.1 (-1.24%)

EXC

Exelon

$37.21

0.71 (1.95%)

WPX

WPX Energy

$9.30

-0.05 (-0.53%)

DRQ

Dril-Quip

$49.20

0.55 (1.13%)

EPD

Enterprise Products

$26.54

0.24 (0.91%)

TTI

TETRA

MTDR

Matador

$20.55

-0.19 (-0.92%)

DNR

Denbury Resources

$1.53

0.08 (5.52%)

MPLX

MPLX

$32.71

0.69 (2.15%)

MPC

Marathon Petroleum

$51.33

-0.17 (-0.33%)

CXO

Concho Resources

$115.91

-0.57 (-0.49%)

EGN

Energen

$48.28

0.35 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

BCO

Brink's

$66.35

0.15 (0.23%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Goldman to hold a conference »

European Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$63.78

0.37 (0.58%)

, COF

Capital One

$80.59

1.07 (1.35%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Money 20/20 to hold conference »

Money 20/20 is being held…

C

Citi

$63.78

0.37 (0.58%)

COF

Capital One

$80.59

1.07 (1.35%)

UBS

UBS

$16.24

0.18 (1.12%)

MITK

Mitek Systems

$8.45

0.05 (0.60%)

INTC

Intel

$34.07

-0.12 (-0.35%)

BAC

Bank of America

$22.89

0.07 (0.31%)

V

Visa

$95.22

-0.36 (-0.38%)

DFS

Discover

$60.61

0.57 (0.95%)

CS

Credit Suisse

$13.97

0.23 (1.67%)

GOOG

Alphabet

$952.27

-13.32 (-1.38%)

DB

Deutsche Bank

$16.88

0.24 (1.44%)

IT

Gartner

$123.59

-0.39 (-0.31%)

JPM

JPMorgan

$87.24

0.38 (0.44%)

MS

Morgan Stanley

$44.00

0.31 (0.71%)

PYPL

PayPal

$53.74

-0.59 (-1.09%)

MSFT

Microsoft

$70.53

-0.68 (-0.95%)

ORCL

Oracle

$50.86

-0.09 (-0.18%)

AAPL

Apple

$145.82

-0.46 (-0.31%)

BCS

Barclays

$10.18

0.14 (1.39%)

IBM

IBM

$155.23

1.12 (0.73%)

MA

MasterCard

$123.52

-0.49 (-0.40%)

LAZ

Lazard

$45.85

0.09 (0.20%)

SSNLF

Samsung

WU

Western Union

$19.01

-0.16 (-0.83%)

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

AXP

American Express

$82.96

0.74 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 14

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

STE

STERIS

$83.11

0.6 (0.73%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
STERIS management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

HOFT

Hooker Furniture

$40.60

1.2 (3.05%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Hooker Furniture management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

AGCO

AGCO

$67.14

0.32 (0.48%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
AGCO management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 10

    Aug

LGF

Use LGF.A, LGF.B

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Use LGF.A, LGF.B management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MITL

Mitel

$7.27

-0.06 (-0.82%)

04:55
06/27/17
06/27
04:55
06/27/17
04:55
Conference/Events
Mitel management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.